Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evacetrapib PK Interaction with Omeprazole
NCT02365558Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of evacetrapib in dyslipidemia, sponsored by Eli Lilly and Company. Primary endpoints: Maximum Observed Concentration at Day 14, Time of Maximum Observed Concentration at Day 14 and 1 more. Started Jan 2015; status: completed.
02
Drugs
evacetrapib
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02365558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02365558.